SandboxAQ · 2 days ago
VP of Business Development, BioSim
United States
Full-time
Remote
Director/Executive
$181K/yr - $348K/yr
15+ years expSandboxAQ is a high-growth company delivering AI solutions that address some of the world's greatest challenges. The VP of Business Development for BioSim will lead the commercial strategy and negotiations for AI-driven drug discovery partnerships, driving growth and establishing key relationships within the biopharma sector.
Artificial Intelligence (AI)Cyber SecurityInformation TechnologyQuantum ComputingSaaS
Responsibilities
Orchestrate Complex Partnerships: Lead the end-to-end negotiation of first-of-their-kind commercial collaborations with global biopharma leaders, focusing on deals with significant upfront value and long-term milestones
Drive Strategic Growth: Formulate and implement a global commercial strategy for the BioSim group, identifying new market opportunities and ensuring our pricing models reflect the transformative value of our technology
Lead and Mentor as a Player-Coach: Manage a specialized commercial team, providing hands-on guidance on deal structuring while personally maintaining accountability for high-stakes strategic accounts
Cultivate Executive Relationships: Act as the primary commercial point of contact for Heads of R&D and Innovation, building deep trust through a sophisticated understanding of their scientific and business needs
Establish Commercial Rigor: Implement robust sales processes and qualification frameworks to ensure a transparent, predictable, and data-driven deal pipeline that aligns with company-wide growth targets
Qualification
Required
15+ years of experience in biopharma or biotech business development or strategic transactions, demonstrating the ability to navigate high-stakes, multi-stakeholder negotiation environments. Experience selling Saas and consulting services a plus
Demonstrated success managing sales of specialty products across multiple market segments. Have built an organization inclusive of existing accounts and net new deals
Proven track record overseeing the full customer experience, including field sales, technical service, application support, and customer care. Experience in pricing value-based engagements inclusive of joint development, consulting and product
An extensive, pre-existing professional network of senior-level contacts (Chief Technology Officers, Heads of Innovation, Heads of R&D) across the global biopharma industry, with a proven ability to initiate strategic conversations from scratch
A documented track record of personally leading and closing complex biopharma technology deals with $20M+ upfront and milestones exceeding $100M
Expert-level proficiency in deal qualification and pipeline management, leveraging data-driven insights to align commercial activities with overall enterprise strategy
Demonstrated leadership in an entrepreneurial or high-growth environment, with the ability to lead a team through ambiguity and make decisive strategic choices
Preferred
Significant industry influence, with previous deal successes featured in major publications like FiercePharma or FierceBiotech
Scientific fluency that allows for seamless communication with both research scientists and C-suite business leaders to bridge technical capabilities with commercial value
Experience leading commercial transformation or building high-performance commercial functions from the ground up
Advanced proficiency in leveraging CRM systems (Salesforce) to optimize customer management and revenue tracking
A history of managing large-scale, global accounts and navigating diverse value-chain partners in the tech-bio sector
Understanding of and fluency with the modern drug discovery landscape inclusive of data models and AI-based tools
Benefits
Comprehensive medical, dental, and vision coverage for employees and dependents with generous employer premium contributions
Retirement savings with company matching
Paid parental leave
Inclusive family-building benefits
Flexible paid time off
Company-wide seasonal breaks
Support for flexible work arrangements that enable sustainable performance
Opportunities for continuous learning and growth through on-the-job development, cross-functional collaboration, and access to internal learning and development programs
Company
SandboxAQ
SandboxAQ develops AI and quantum technology solutions that enhance biopharma, cybersecurity, and materials science.
51-200 employees
Funding
Current Stage
Late StageTotal Funding
$975MKey Investors
Eric Schmidt Angel InvestmentsMichael J. Fox Foundation
2025-04-04Series E· $150M
2024-12-18Series E· $300M
2024-10-29Grant· $25M
Leadership Team
Jack Hidary
Chief Executive Officer
Joerg Rathenberg
Head Of Marketing
Recent News
2026-01-10
Company data provided by crunchbase